Compare CRL & REG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | REG |
|---|---|---|
| Founded | 1947 | 1963 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.1B | 13.4B |
| IPO Year | 1999 | 1994 |
| Metric | CRL | REG |
|---|---|---|
| Price | $287.00 | $71.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 20 |
| Target Price | ★ $298.79 | $86.56 |
| AVG Volume (30 Days) | 769.7K | ★ 1.1M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 4.20% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | ★ $1,857,601,000.00 | $1,553,524,000.00 |
| Revenue This Year | N/A | $1.44 |
| Revenue Next Year | $2.24 | $3.88 |
| P/E Ratio | ★ N/A | $157.73 |
| Revenue Growth | ★ 10.48 | 6.85 |
| 52 Week Low | $146.20 | $66.86 |
| 52 Week High | $303.31 | $83.66 |
| Indicator | CRL | REG |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 26.13 |
| Support Level | $267.27 | $70.15 |
| Resistance Level | $303.31 | $76.97 |
| Average True Range (ATR) | 9.76 | 0.99 |
| MACD | 0.78 | -0.08 |
| Stochastic Oscillator | 83.37 | 0.87 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 482 properties, which includes over 58 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.